Organobeidellites for Removal of Anti-Inflammatory Drugs from Aqueous Solutions

Diclofenac (DC) and ibuprofen (IBU) are widely prescribed non-steroidal anti-inflammatory drugs, the consumption of which has rapidly increased in recent years. The biodegradability of pharmaceuticals is negligible and their removal efficiency by wastewater treatment is very low. Therefore, the beid...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Eva Plevová, Silvie Vallová, Lenka Vaculíková, Marianna Hundáková, Roman Gabor, Kateřina Smutná, Radim Žebrák
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/f60875099099497a898005a8df8adb12
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f60875099099497a898005a8df8adb12
record_format dspace
spelling oai:doaj.org-article:f60875099099497a898005a8df8adb122021-11-25T18:32:29ZOrganobeidellites for Removal of Anti-Inflammatory Drugs from Aqueous Solutions10.3390/nano111131022079-4991https://doaj.org/article/f60875099099497a898005a8df8adb122021-11-01T00:00:00Zhttps://www.mdpi.com/2079-4991/11/11/3102https://doaj.org/toc/2079-4991Diclofenac (DC) and ibuprofen (IBU) are widely prescribed non-steroidal anti-inflammatory drugs, the consumption of which has rapidly increased in recent years. The biodegradability of pharmaceuticals is negligible and their removal efficiency by wastewater treatment is very low. Therefore, the beidelitte (BEI) as unique nanomaterial was modified by the following different surfactants: cetylpyridinium (CP), benzalkonium (BA) and tetradecyltrimethylammonium (TD) bromides. Organobeidellites were tested as potential nanosorbents for analgesics. The organobeidellites were characterized using X-ray powder diffraction (XRD), Infrared spectroscopy (IR), Thermogravimetry and differential thermal analysis (TG/DTA) and scanning microscopy (SEM). The equilibrium concentrations of analgesics in solution were determined using UV-VIS spectroscopy. The intercalation of surfactants into BEI structure was confirmed both using XRD analysis due to an increase in basal spacing from 1.53 to 2.01 nm for BEI_BA and IR by decreasing in the intensities of bands related to the adsorbed water. SEM proved successful in the uploading of surfactants by a rougher and eroded organobeidellite surface. TG/DTA evaluated the decrease in dehydration/dehydroxylation temperatures due to higher hydrophobicity. The Sorption experiments demonstrated a sufficient sorption ability for IBU (55–86%) and an excellent ability for DC (over 90%). The maximum adsorption capacity was found for BEI_BA-DC (49.02 mg·g<sup>−1</sup>). The adsorption according to surfactant type follows the order BEI_BA > BEI_TD > BEI_CP.Eva PlevováSilvie VallováLenka VaculíkováMarianna HundákováRoman GaborKateřina SmutnáRadim ŽebrákMDPI AGarticleorganobeidellitesorptionibuprofendiclofenaccetylpyridinium bromidebenzalkonium bromideChemistryQD1-999ENNanomaterials, Vol 11, Iss 3102, p 3102 (2021)
institution DOAJ
collection DOAJ
language EN
topic organobeidellite
sorption
ibuprofen
diclofenac
cetylpyridinium bromide
benzalkonium bromide
Chemistry
QD1-999
spellingShingle organobeidellite
sorption
ibuprofen
diclofenac
cetylpyridinium bromide
benzalkonium bromide
Chemistry
QD1-999
Eva Plevová
Silvie Vallová
Lenka Vaculíková
Marianna Hundáková
Roman Gabor
Kateřina Smutná
Radim Žebrák
Organobeidellites for Removal of Anti-Inflammatory Drugs from Aqueous Solutions
description Diclofenac (DC) and ibuprofen (IBU) are widely prescribed non-steroidal anti-inflammatory drugs, the consumption of which has rapidly increased in recent years. The biodegradability of pharmaceuticals is negligible and their removal efficiency by wastewater treatment is very low. Therefore, the beidelitte (BEI) as unique nanomaterial was modified by the following different surfactants: cetylpyridinium (CP), benzalkonium (BA) and tetradecyltrimethylammonium (TD) bromides. Organobeidellites were tested as potential nanosorbents for analgesics. The organobeidellites were characterized using X-ray powder diffraction (XRD), Infrared spectroscopy (IR), Thermogravimetry and differential thermal analysis (TG/DTA) and scanning microscopy (SEM). The equilibrium concentrations of analgesics in solution were determined using UV-VIS spectroscopy. The intercalation of surfactants into BEI structure was confirmed both using XRD analysis due to an increase in basal spacing from 1.53 to 2.01 nm for BEI_BA and IR by decreasing in the intensities of bands related to the adsorbed water. SEM proved successful in the uploading of surfactants by a rougher and eroded organobeidellite surface. TG/DTA evaluated the decrease in dehydration/dehydroxylation temperatures due to higher hydrophobicity. The Sorption experiments demonstrated a sufficient sorption ability for IBU (55–86%) and an excellent ability for DC (over 90%). The maximum adsorption capacity was found for BEI_BA-DC (49.02 mg·g<sup>−1</sup>). The adsorption according to surfactant type follows the order BEI_BA > BEI_TD > BEI_CP.
format article
author Eva Plevová
Silvie Vallová
Lenka Vaculíková
Marianna Hundáková
Roman Gabor
Kateřina Smutná
Radim Žebrák
author_facet Eva Plevová
Silvie Vallová
Lenka Vaculíková
Marianna Hundáková
Roman Gabor
Kateřina Smutná
Radim Žebrák
author_sort Eva Plevová
title Organobeidellites for Removal of Anti-Inflammatory Drugs from Aqueous Solutions
title_short Organobeidellites for Removal of Anti-Inflammatory Drugs from Aqueous Solutions
title_full Organobeidellites for Removal of Anti-Inflammatory Drugs from Aqueous Solutions
title_fullStr Organobeidellites for Removal of Anti-Inflammatory Drugs from Aqueous Solutions
title_full_unstemmed Organobeidellites for Removal of Anti-Inflammatory Drugs from Aqueous Solutions
title_sort organobeidellites for removal of anti-inflammatory drugs from aqueous solutions
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/f60875099099497a898005a8df8adb12
work_keys_str_mv AT evaplevova organobeidellitesforremovalofantiinflammatorydrugsfromaqueoussolutions
AT silvievallova organobeidellitesforremovalofantiinflammatorydrugsfromaqueoussolutions
AT lenkavaculikova organobeidellitesforremovalofantiinflammatorydrugsfromaqueoussolutions
AT mariannahundakova organobeidellitesforremovalofantiinflammatorydrugsfromaqueoussolutions
AT romangabor organobeidellitesforremovalofantiinflammatorydrugsfromaqueoussolutions
AT katerinasmutna organobeidellitesforremovalofantiinflammatorydrugsfromaqueoussolutions
AT radimzebrak organobeidellitesforremovalofantiinflammatorydrugsfromaqueoussolutions
_version_ 1718411053417627648